Ahmed Kotb/X
Jul 26, 2026, 13:32
Ahmed Kotb: A Practical Guide to Von Willebrand Disease
Ahmed Kotb, Hematologist and Bone Marrow Transplant Physician at King Faisal Specialist Hospital International Holding Company (KFSHI), shared a post on X:
”Von Willebrand Disease (VWD)
Type 1: Partial decrease in von Willebrand factor (VWF) – usually responds to desmopressin (DDAVP).
Type 2: Qualitative defect in VWF.
- Type 2A: Decreased high-molecular-weight (HMW) multimers.
- Type 2B: Increased binding to platelet glycoprotein Ib (GPIb), resulting in thrombocytopenia; avoid DDAVP.
- Type 2M: Decreased platelet adhesion.
- Type 2N: Decreased binding to factor VIII (FVIII).
Type 3: Complete absence of VWF, causing severe disease; treat with VWF/FVIII concentrate.
Laboratory findings: Decreased VWF antigen, decreased VWF activity, and factor VIII may be decreased.”
Stay updated with Hemostasis Today.
-
Sep 20, 2026, 12:11Giacomo Buso: Silent Atherosclerosis Begins Earlier Than Expected
-
Sep 20, 2026, 12:0310 Posts Not to Miss This Week
-
Sep 20, 2026, 11:27Edward Lee Carter: Prasugrel Dosing Matters in P2Y12 Inhibitor Comparisons After PCI
-
Sep 20, 2026, 09:51Ceasovschih Alexandr: A Closer Look at Lipid Disorders in CKM Syndrome
-
Sep 20, 2026, 09:05World Stroke Academy: Can Adjunct IAT Improve Tissue Reperfusion?
-
Sep 20, 2026, 06:46Neeraj Songara: From Donated Blood to Engineered Therapeutics
-
Sep 20, 2026, 06:24Louise St. Germain Bannon: Improving Awareness and Care for Women Across the Lifespan
-
Sep 20, 2026, 05:17Maxime Dely: When ABO Compatibility Isn’t Enough for Safe Transfusion
-
Sep 20, 2026, 04:54William Aird: What Does a Complete History and Physical Really Mean?